快速脑 tau 蛋白积聚与罕见神经疾病进展加快相关
Faster brain tau buildup linked to faster progression of rare neurological disease
日本量子科学技术研究所(QST)研究团队在《Movement Disorders》发表研究,证实进行性核上性麻痹(PSP)患者脑内 tau 蛋白积聚速度与其临床症状恶化程度密切相关。该研究利用氟正托(florzolotau)PET 显像剂追踪 26 名 PSP 患者,发现苍白球区 tau 积聚增加量较大的患者,其 PSP 评估量表得分恶化更显著。
A team of researchers from the National Institutes for Quantum Science and Technology (QST) has shown that the speed at which abnormal tau protein accumulates in the brains of people with progressive supranuclear palsy (PSP) is closely linked to how quickly their symptoms worsen. The discovery could help researchers objectively measure disease progression and accelerate the development of treatments for this rare neurological disorder. This study was published in Movement Disorders on Sept. 4, 2026.
PSP is a progressive neurodegenerative disease that typically develops in middle-aged and older adults. Patients experience increasing difficulty with balance, motor function, eye movements and cognition. Although abnormal accumulation of tau protein is known to be a hallmark of the disease, scientists have long struggled to determine how changes in tau over time relate to the worsening of symptoms in living patients.
To address this challenge, the researchers used florzolotau (18F) ([¹⁸F]PM-PBB3), a highly sensitive tau PET tracer developed by QST, to follow 26 people with PSP and 10 healthy volunteers over approximately one year. By comparing PET scans taken at two time points, the team examined how tau accumulation changed throughout the brain and whether those changes were associated with clinical decline.
The study revealed that tau accumulation increased over time in several brain regions affected by PSP, including the basal ganglia, frontal and parietal cortices, and the cerebellum. Among patients with Richardson's syndrome, the most common and fastest-progressing form of PSP, greater increases in tau accumulation within the globus pallidus were strongly associated with greater worsening of symptoms. Patients whose tau burden increased more rapidly experienced faster disease progression.
The findings provide some of the strongest longitudinal imaging evidence to date that changes in PET-measured tau pathology are associated with clinical deterioration in PSP. They also suggest that therapies capable of slowing tau accumulation may help slow the course of the disease itself.
"Until now, we could see tau pathology in the brains of people with PSP, but we did not know whether changes in tau over time truly reflected the progression of symptoms," said Hironobu Endo, principal researcher at the Advanced Neuroimaging Center, Institute for Quantum Medical Science, QST. "Our study demonstrates that patients with faster tau accumulation experience faster clinical decline. This provides important support for the development of treatments aimed at reducing tau pathology and offers a promising imaging biomarker for evaluating their effectiveness."
Beyond PSP, the researchers believe the imaging approach could benefit studies of other neurological disorders in which tau plays a central role, including Alzheimer's disease and related dementias. Because the method can detect changes over time even in relatively small patient groups, it may help researchers evaluate new therapies more efficiently and objectively.
Looking ahead, the researchers believe that imaging biomarkers such as this could accelerate the development of disease-modifying therapies, enable clinicians to monitor disease progression more precisely, and help patients maintain independence for longer while reducing the burden on caregivers.
More information
Yoshikazu Chishiki et al., Spatiotemporal Tau Accumulation and its Clinical Impact on Progressive Supranuclear Palsy: Longitudinal Florzolotau (18F) Positron Emission Tomography, Movement Disorders (2026). DOI: 10.1002/mds.70468
Who's behind this story?
Gaby Clark
MA in English, copy editor since 2021 with experience in higher education and health content. Dedicated to trustworthy science news. Full profile →
Andrew Zinin
Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →
Citation: Faster brain tau buildup linked to faster progression of rare neurological disease (2026, October 27) retrieved 27 October 2026 from https://medicalxpress.com/news/2026-10-faster-brain-tau-buildup-linked.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
来源:Medical Xpress · medicalxpress.com